ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,010 DKK | -7.76% |
|
+2.20% | -24.06% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
1077036306d324f7e2deef14e406be.PVoFNbnEHMwampb2GdAmnXS3Fk0MzwwIViai5k1xISM.cBB9Zcj8VoQs9aKmLp5N2xbbcyw5jWZyP1THrh08b3VqCGkFwYYvlnOt3w~3c686b5568577658cbd9f7555e58c1c3
